Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-naive Patients With Type 2 Diabetes Treated With Metformin and Not Adequately Controlled.

Next Previous
Trial Profile

Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-naive Patients With Type 2 Diabetes Treated With Metformin and Not Adequately Controlled.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Insulin glargine (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms EASIE
  • Sponsors Sanofi

    • Most Recent Events

    • 15 Sep 2012 Last checked against European Clinical Trials Database record (Parent trial: EudraCT2008-000516-32)
    • 12 Jun 2012 Results published in the Lancet.
    • 09 Jun 2012 Results were reported at the 72nd Scientific Sessions of the American Diabetes Association, and in a Sanofi media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top